Decentralized Study to Evaluate a Dietary Supplement for Episodes of Mild Acute Stress in Healthy People

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorPLT Health Solutions

About this trial

The purpose of this decentralized, two-arm, double-blinded, crossover clinical study is to test the efficacy of a supplement to reduce symptoms of acute stress or situational anxiety in healthy volunteers. The main questions it aims to answer are:

1. Does a dietary supplement reduce feelings of anxiety after self-identified episodes of stress or anxiety when compared to their experience after taking a placebo? 2. On a scale of 1-5, how much would the volunteer like to take the assigned treatment in the future? 3. Are any adverse events identified after either treatment, supplement, or placebo?

The study volunteers will:

During weeks 1-2, self-identify episodes of acute stress or situational anxiety and rate feelings of anxiety over the next five hours after taking the study product assigned for Period 1.

During week 3, volunteers will not take any study product nor complete any surveys.

During weeks 4-5, self-identify an episode of acute stress or situational anxiety and rate feelings of anxiety over the next five hours after taking the study product assigned for Period 2.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Female and male subjects aged >18 and <60 years.

Self-reported experience of episodic stress or situational anxiety of ≥1 x per week.

Score of ≥ 40 on a self-assessment of typical anxiety on a Visual Analog Scale where 0 represents "not stressed or anxious" and 100 represents "extremely stressed or anxious."

Score of ≥ 20 on the Positive Reactivity component of the Perth Emotional Reactivity Scale- Short Form (PERS-S).

Disqualifiers

Score of > 9 on the Patient Health Questionnaire (PHQ-9) or any response > 0 on question 9 of the PHQ-9.

Score > 24 on the Hamilton Anxiety Scale (HAM-A).

History of severe psychiatric or medical conditions that would interfere with participation.

Use of >14 alcoholic drinks per week.

Trial design

Design model

Crossover

Treatments tested in this trial

  • Botanical extract for anxiety

    Dietary supplement

    Capsule containing botanical extracts is self-administered by mouth, taken as needed once per day.

  • Placebo capsule

    Dietary supplement

    Capsule containing inert excipients only

Treatment groups

250 Participants
are divided into 2 treatment groups
Group A: Dietary SupplementActive comparator 1 intervention
Group B: PlaceboPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Visual Analog Scale Score

Change in anxiety VAS score

Time frame
30 minutes after intervention administration
2

Visual Analog Scale Score

Change in anxiety VAS score

Time frame
60 minutes after intervention administration
3

Visual Analog Scale Score

Change in anxiety VAS score

Time frame
120 minutes after intervention administration

Secondary outcomes

1

Adverse Events

Tolerance

Time frame
Throughout study completion, an average of 35 days

Other outcomes

1

End of Treatment Arm Survey

Satisfaction/desire to take intervention again

Time frame
Day 14 and Day 35

Sponsors and contacts

Click on the lead sponsor to view all of their trials.